Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention.
Brian WoodAnd Craig R LeeIan R MulreninMegan N GowerJoseph S RossiKaren E WeckGeorge A StoufferPublished in: Pharmacotherapy (2021)
This study suggests important clinical benefits of CYP2C19 genotype-guided antiplatelet therapy after PCI in both younger and older patients.